Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study-Reference-Cited by-同舟云学术

Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study

Published:2011-12-15 Issue:3 Volume:106 Page:460-467
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Royer B,Kalbacher E,Onteniente S,Jullien V,Montange D,Piedoux S,Thiery-Vuillemin A,Delroeux D,Pili-Floury S,Guardiola E,Combe M,Muret P,Nerich V,Heyd B,Chauffert B,Kantelip J-P,Pivot X

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2011557.pdf

Reference43 articles.

1. Aebi S, Castiglione M (2008) Epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 19 (Suppl 2): ii14–ii16

2. Alberts DS, Liu PY, Hannigan EV, O’Toole R, Williams SD, Young JA, Franklin EW, Clarke-Pearson DL, Malviya VK, DuBeshter B (1996) Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med 335: 1950–1955

3. Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, Copeland LJ, Walker JL, Burger RA (2006) Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354: 34–43

4. Beal SL, Sheiner LB, Boeckmann AJ NONMEM Users Guides. Ellicott City MD 1989-2006

5. Brendel K, Comets E, Laffont C, Laveille C, Mentre F (2006) Metrics for external model evaluation with an application to the population pharmacokinetics of gliclazide. Pharm Res 23: 2036–2049

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Importance of Computational Models in the Development of Intraperitoneal Administration-Based Drug Delivery Systems for Solid Tumors;Exploring Drug Delivery to the Peritoneum;2023

2. Cytoreductive Surgery and Intraperitoneal Chemotherapy in Advanced Serous Epithelial Ovarian Cancer: A 14-Year French Retrospective Single-Center Study of 124 Patients;Annals of Surgical Oncology;2022-01-07

3. PKPD Modeling and Dosing Considerations in Advanced Ovarian Cancer Patients Treated with Cisplatin-Based Intraoperative Intraperitoneal Chemotherapy;The AAPS Journal;2020-07-24

4. A 3D CFD model of the interstitial fluid pressure and drug distribution in heterogeneous tumor nodules during intraperitoneal chemotherapy;Drug Delivery;2019-01-01

5. Pharmacokinetics and Tissue Transport of Intraperitoneal Chemotherapy;Surgical Oncology Clinics of North America;2018-07